STOCK TITAN

Large CRWV 10b5-1 stock sales and new 500-share plan (NASDAQ: CRWV)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

CRWV has a Form 144 notice covering a proposed sale of 500 shares of its common stock through Morgan Stanley Smith Barney, with an aggregate market value of $48,020. The shares are described as founders’ common stock acquired from the issuer on 02/25/2019 and fully paid that day.

The filing also lists extensive recent Rule 10b5-1 sales of CRWV common stock during the prior three months by multiple named sellers, including BRANNIN MCBEE, the Brannin J. McBee 2022 Irrevocable Trust, several Canis Major and Canis Minor family and GRAT trusts, and a Non-Affiliate Donee. Individual entries show large blocks such as 102,835 shares sold for over $10 million and 257,733 shares sold for about $19.6 million, illustrating significant ongoing disposition activity under pre-arranged trading plans.

Positive

  • None.

Negative

  • None.

Insights

Form 144 shows a small planned CRWV sale alongside large prior 10b5-1 dispositions.

The notice describes a planned sale of 500 CRWV common shares with aggregate market value of $48,020, originally acquired as founders’ shares on 02/25/2019. This is a modest proposed transaction by itself, executed through Morgan Stanley Smith Barney on NASDAQ.

More notable is the detailed record of recent Rule 10b5-1 sales over the past three months by BRANNIN MCBEE, a related irrevocable trust, several Canis Major and Canis Minor family and GRAT vehicles, and a Non-Affiliate Donee. Individual entries include 102,835 shares sold for up to $10,432,309.16 and 257,733 shares sold for $19,592,527.61.

These figures indicate substantial ongoing selling activity in CRWV common stock via pre-arranged plans, spreading transactions across multiple dates and entities between 12/01/2025 and 02/09/2026. Actual implications for the float or ownership structure depend on total shares outstanding and broader context, which are not detailed in this excerpt.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What CRWV stock sale is disclosed in this Form 144 filing?

The filing covers a planned sale of 500 shares of CRWV common stock, to be sold through Morgan Stanley Smith Barney, with an aggregate market value of $48,020. The shares are founders’ stock originally acquired from the issuer on February 25, 2019.

How were the CRWV shares in the Form 144 originally acquired?

The 500 CRWV common shares in the notice were acquired on February 25, 2019 as founders’ shares directly from the issuer. The table notes that payment was made on the same date, with the nature of payment shown as “N/A,” indicating no separate non-cash consideration disclosure.

What recent 10b5-1 stock sales involving CRWV are listed in the filing?

The document lists numerous Rule 10b5-1 sales of CRWV common stock over the past three months by BRANNIN MCBEE, a 2022 irrevocable trust, several Canis Major and Canis Minor trusts, and a Non-Affiliate Donee, with individual trades ranging from hundreds to more than 250,000 shares each.

What are examples of large CRWV share blocks sold under 10b5-1 plans?

Examples include BRANNIN MCBEE selling 102,835 CRWV shares on multiple dates for proceeds such as $10,432,309.16, and a Non-Affiliate Donee selling 257,733 shares on December 1, 2025 for $19,592,527.61. Several Canis Major and Canis Minor trusts also sold sizable blocks.

What representation does the seller make about CRWV information in this Form 144?

The person for whose account the securities are sold represents that they do not know any material adverse information about CRWV’s current or prospective operations that has not been publicly disclosed. This statement is part of the standard Form 144 signature and certification language.

Which broker is handling the planned CRWV Form 144 sale and where will it trade?

The proposed 500-share CRWV sale is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at One New York Plaza. The filing identifies NASDAQ as the securities exchange where the common stock will be sold.